Stuart Gibb
Scientific Strategy Lead • Terumo Blood and Cell Technologies
Stuart has an unapologetic passion for Cell therapies. Educated with a Ph.D from Cambridge University in Neuroscience, Stuart has investigated several neurodegenerative disorders and evolved his interests from discovery research to interventional cell and gene therapies. Stuart has spent the last 10 years employing hollow-fiber bioreactors to unmet medical needs from the culture of MSCs, to exosome and viral vectors generation and also suspension cells expansion
Also Speaking
Pete Robinson
Vice President, Medical and Scientific Management, Head, Cell and Gene Therapy Consortium • Syneos Health
24 November 2022
Also Speaking
2025 Downloadable Agenda
Download the post-event report for Advanced Therapies Week 2024.
8 October 2024
